Immucell initiates Investigational Product use of Re-Tain

ImmuCell (ICCC) announced that it is initiating Investigational Product use of Re-Tain. The company intends to use this opportunity to test market acceptance of the product through a controlled launch. This initiative also helps the company utilize available inventory before shelf-life expiration. This opportunity is not expected to generate significant revenue or profit.